InterContinental New York Barclay Hotel

Cars.com to Participate in Three Investor Conferences in November

Retrieved on: 
Thursday, November 9, 2023

CHICAGO, Nov. 9, 2023 /PRNewswire/ -- Cars.com Inc .

Key Points: 
  • CHICAGO, Nov. 9, 2023 /PRNewswire/ -- Cars.com Inc .
  • d/b/a Cars Commerce (NYSE: CARS) ("Cars Commerce"), an audience-driven technology company empowering the automotive industry, today announced that Alex Vetter, Chief Executive Officer of Cars Commerce and Sonia Jain, Chief Financial Officer of Cars Commerce will host meetings at the following three investor conferences in November:
    Conference: RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference
    Fireside Chat: A webcast of the 1:50 p.m.
  • ET fireside chat will be accessible on the Events section of the Cars.com website and will be archived on that website
    Location: InterContinental New York Barclay Hotel, New York
    Location: The Thompson Central Park Hotel, New York
    To schedule a one-on-one meeting, please contact your representative at RBC Capital Markets, D. A. Davidson and Needham.

SS&C to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, November 8, 2023

WINDSOR, Conn., Nov. 8, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of software and software-enabled services for the financial services and healthcare industries, today announced that senior management will participate in the following investor conferences.

Key Points: 
  • WINDSOR, Conn., Nov. 8, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC), a global provider of software and software-enabled services for the financial services and healthcare industries, today announced that senior management will participate in the following investor conferences.
  • Bill Stone, Chairman and CEO, will present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on Tuesday, November 14, 2023 at the InterContinental New York Barclay in New York, NY at 2:40 pm ET.
  • Rahul Kanwar, President and Chief Operating Officer, and Brian Schell, Senior Vice President and Chief Financial Officer, will present at the D.A.
  • Davidson Technology Summit on Thursday, November 16, 2023 at the Thompson Central Park Hotel in New York, NY at 2:00 pm ET.

Powerfleet and MiX Telematics to Host Joint Investor Day on November 16, 2023

Retrieved on: 
Monday, October 30, 2023

WOODCLIFF LAKE, N.J., Oct. 30, 2023 /PRNewswire/ -- PowerFleet, Inc. (Nasdaq: PWFL) and MiX Telematics Limited (NYSE: MIXT, JSE: MIX) will host a joint Investor Day with financial analysts and institutional investors on Thursday, November 16 at The InterContinental New York Barclay hotel in New York, NY.

Key Points: 
  • WOODCLIFF LAKE, N.J., Oct. 30, 2023 /PRNewswire/ -- PowerFleet, Inc. (Nasdaq: PWFL) and MiX Telematics Limited (NYSE: MIXT, JSE: MIX) will host a joint Investor Day with financial analysts and institutional investors on Thursday, November 16 at The InterContinental New York Barclay hotel in New York, NY.
  • Presentations are scheduled to begin at 2:00 p.m. Eastern time and end at approximately 5:00 p.m. Eastern time.
  • For those who would like to attend the event in-person, please contact respectively Powerfleet's investor relations team at [email protected] or MiX's investor relations team at [email protected] .
  • A live webcast will be available on the investor relations section of each company's website.

Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference

Retrieved on: 
Tuesday, September 26, 2023

Toronto, Ontario--(Newsfile Corp. - September 26, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that Cardiol's President and CEO, David Elsley, will present a company overview today which will be broadcast live at the Cantor Fitzgerald 2023 Global Healthcare Conference, at the InterContinental New York Barclay Hotel, on September 26, 2023, at 4:55 p.m. EDT.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - September 26, 2023) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, is pleased to announce that Cardiol's President and CEO, David Elsley, will present a company overview today which will be broadcast live at the Cantor Fitzgerald 2023 Global Healthcare Conference, at the InterContinental New York Barclay Hotel, on September 26, 2023, at 4:55 p.m. EDT.

Vista Outdoor to Host Investor Day

Retrieved on: 
Tuesday, September 26, 2023

Vista Outdoor Inc. (NYSE: VSTO), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor lifestyle products to consumers around the globe, will host an Investor Day for institutional investors and analysts.

Key Points: 
  • Vista Outdoor Inc. (NYSE: VSTO), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor lifestyle products to consumers around the globe, will host an Investor Day for institutional investors and analysts.
  • Presenters include Vista Outdoor Interim CEO Gary McArthur, Sporting Products President and CEO Jason Vanderbrink, Outdoor Products CEO Eric Nyman, Vista Outdoor Interim CFO Andrew Keegan and leaders from several of the company’s business units.
  • On the day of the event, individuals may also access the webcast and related presentation materials from the Vista Outdoor website ( https://vistaoutdoor.com ).
  • The company expects to create these companies through a tax-free spin-off of its Outdoor Products segment to Vista Outdoor shareholders.

Humacyte to Present at the Cantor Global Healthcare Conference

Retrieved on: 
Thursday, September 21, 2023

DURHAM, N.C., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Cantor Global Healthcare Conference, in New York, NY on September 28, 2023.

Key Points: 
  • DURHAM, N.C., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Cantor Global Healthcare Conference, in New York, NY on September 28, 2023.
  • Management will also be available for one-on-one meetings.
  • Location: InterContinental New York Barclay Hotel, New York, NY
    A replay will be available for a limited time following the presentation on the Events & Presentations portion of the Humacyte website.

Veru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023

Retrieved on: 
Wednesday, September 20, 2023

MIAMI, FL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for metastatic breast cancer and for viral induced acute respiratory distress syndrome (ARDS), today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will participate in a fireside chat at the 2023 Cantor Fitzgerald Global Healthcare Conference to be held at the InterContinental New York, Barclay Hotel in New York City on September 28th, 2023 at 10:55 a.m.

Key Points: 
  • MIAMI, FL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing novel medicines for metastatic breast cancer and for viral induced acute respiratory distress syndrome (ARDS), today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer of Veru, will participate in a fireside chat at the 2023 Cantor Fitzgerald Global Healthcare Conference to be held at the InterContinental New York, Barclay Hotel in New York City on September 28th, 2023 at 10:55 a.m.
  • ET.
  • A live webcast will be accessible through the Investors section of the Company’s website at www.verupharma.com .
  • Following the event, an archived webcast will be available on the Veru website.

Erasca to Present at the Cantor Global Healthcare Conference

Retrieved on: 
Tuesday, September 19, 2023

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in a fireside chat on Tuesday, September 26, 2023, at 8:10 am Eastern Time at the Cantor Global Healthcare Conference, which is being held at the InterContinental New York Barclay in New York, New York.

Key Points: 
  • SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in a fireside chat on Tuesday, September 26, 2023, at 8:10 am Eastern Time at the Cantor Global Healthcare Conference, which is being held at the InterContinental New York Barclay in New York, New York.
  • Management will also participate in one-on-one investor meetings.

Lineage to Present at Cantor Fitzgerald 2023 Global Healthcare Conference on September 27, 2023

Retrieved on: 
Tuesday, September 19, 2023

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief Executive Officer, will present at the Cantor Fitzgerald 2023 Global Healthcare Conference , in a fireside chat hosted by Kristen Kluska, Managing Director, Biotechnology Equity Research, Cantor Fitzgerald & Co., on September 27th, 2023 at 9:10am ET.

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Brian M. Culley, Lineage’s Chief Executive Officer, will present at the Cantor Fitzgerald 2023 Global Healthcare Conference , in a fireside chat hosted by Kristen Kluska, Managing Director, Biotechnology Equity Research, Cantor Fitzgerald & Co., on September 27th, 2023 at 9:10am ET.
  • The Cantor Fitzgerald 2023 Global Healthcare Conference is being held at the InterContinental New York Barclay Hotel.
  • Interested parties can register to view a replay of the presentation on the Events and Presentations section of Lineage’s website.
  • Additional videos are available on the Media page of the Lineage website.

Cytokinetics to Participate in Upcoming Investor Conferences

Retrieved on: 
Thursday, September 7, 2023

H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 8:30 AM Eastern Time in a presentation with Robert I. Blum, President and Chief Executive Officer, at the Lotte New York Palace in New York, NY.

Key Points: 
  • H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023 at 8:30 AM Eastern Time in a presentation with Robert I. Blum, President and Chief Executive Officer, at the Lotte New York Palace in New York, NY.
  • Cantor Fitzgerald Global Healthcare Conference 2023 on Wednesday, September 27, 2023 at 1:50 PM Eastern Time in a fireside chat with Robert I. Blum, President and Chief Executive Officer, at the InterContinental New York Barclay in New York, NY.
  • Interested parties may access the live webcasts of the fireside chats and presentation by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com .
  • The webcast replay will be archived on the Cytokinetics website for 90 days following the conclusion of the event.